Management of tinea capitis in infants and children in the United States: A national survey of pediatric dermatologists

This study aimed to evaluate the current management of tinea capitis in the United States, specifically focusing on patients aged 0-2 months, 2 months to 2 years, and 2 years to 18 years. An online survey, distributed through the Pediatric Dermatology Research Alliance and the Society of Pediatric D...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric dermatology 2024-03, Vol.41 (2), p.263-265
Main Authors: Guo, Lily, Tran, Jacqueline, Sun, Dingyuan Iris, Newton, Jazmin Starr, D'Amiano, Nina M, Lai, Jonathan, Cohen, Bernard
Format: Article
Language:English
Subjects:
Fluconazole
Griseofulvin
Pediatrics
Surveys
Terbinafine
Tinea capitis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to evaluate the current management of tinea capitis in the United States, specifically focusing on patients aged 0-2 months, 2 months to 2 years, and 2 years to 18 years. An online survey, distributed through the Pediatric Dermatology Research Alliance and the Society of Pediatric Dermatology, revealed the following preferences: fluconazole for those under 2 months, griseofulvin for those aged 2 months to 2 years, and terbinafine for those aged 2 years and older. There exists inter-provider variation in tinea capitis treatment regimens within the pediatric dermatology community.
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.15544